NCT03049449
- Conditions
- Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,018 public trials
2,029 recruiting studies
Immunoproliferative Disorders trial results
NCT04158128
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT02758665
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
- Locations
-
- Universitätsklinikum Köln Cologne, Germany
- BAG Onkologische Gemeinschaftspraxis Dresden, Germany
- Universitätsklinikum Essen Essen, Germany
- Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
NCT03109353
- Conditions
- Chronic Graft Versus Host Disease in Skin, Cutaneous T-Cell Lymphoma, Unspecified, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- St Olavs Hospital Trondheim, Norway
NCT03374137
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
- Locations
-
- Inje University Busan Paik Hospital; Hematology-oncology Busan, South Korea
- Pusan National University Hospital Busan, South Korea
- St. Vincent's Hospital Gyeonggi-do, South Korea
- Hallym University Sacred Heart Hospital; Department of Hematology Gyeonggi-do, South Korea
NCT05679817
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Ragab K. Elnaggar Al Kharj, Riyadh Region, Saudi Arabia
NCT02303119
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- CH de Pays d'Aix Aix-en-Provence, France
- CHU Angers Angers, France
- CH d'Avignon - Hôpital Henri Duffaut Avignon, France
- Hôpital de Bayonnes Bayonne, France
Completed
Determination of Blood Tumor Cells
NCT04290923
- Conditions
- Abnormalities Cell Epithelial, Chronic Disease, Colorectal Cancer, Hereditary Nonpolyposis, Type 8, +15 more
- Locations
-
- University Hospital Zurich Zurich, Switzerland
Completed
Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
NCT01796002
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- ZNA Stuivenberg Antwerp, Belgium
- A.Z. Sint Jan AV Bruges, Belgium
- Institut Jules Bordet Brussels, Belgium
- UCL Louvain Saint Luc Brussels, Belgium
Completed
Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas
NCT03276468
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- CHU d'Angers Angers, France
- CHU de Caen Caen, France
- CHU de Clermont Ferrand - Estaing Clermont-Ferrand, France
- Hopital Henri Mondor Créteil, France